Crystal structure of oxibendazole, C12H15N3O3

被引:0
|
作者
Kaduk, James A. A. [1 ,2 ]
Gates-Rector, Stacy [3 ]
Blanton, Thomas N. N. [3 ]
机构
[1] IIT, 3101 S Dearborn St, Chicago, IL 60616 USA
[2] North Cent Coll, 131 S Loomis St, Naperville, IL 60540 USA
[3] ICDD, 12 Campus Blvd, Newtown Sq, PA 19073 USA
关键词
oxibendazole; Loditac; powder diffraction; Rietveld refinement; density functional theory; POWDER; VALIDATION; PATTERNS; DENSITY;
D O I
10.1017/S0885715622000495
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
The crystal structure of oxibendazole has been solved and refined using synchrotron X-ray powder diffraction data, and optimized using density functional theory techniques. Oxibendazole crystallizes in space group C2/c (#15) with a = 23.18673(22), b = 5.35136(5), c = 19.88932(13) angstrom, beta = 97.0876(9)degrees, V = 2449.018(17) angstrom(3), and Z = 8. The structure consists of hydrogen-bonded layers of planar molecules parallel to the bc-plane. Strong N-HMIDLINE HORIZONTAL ELLIPSISN hydrogen bonds link the molecules into dimers, with a graph set R2,2(8). N-HMIDLINE HORIZONTAL ELLIPSISO hydrogen bonds further link these dimers into layers parallel to the bc-plane. The powder pattern has been submitted to ICDD for inclusion in the Powder Diffraction File (TM) (PDF (R)).
引用
收藏
页码:15 / 20
页数:6
相关论文
共 50 条
  • [1] Crystal structure of oxfendazole, C15H13N3O3S
    Kaduk, James A. A.
    Gates-Rector, Stacy
    Blanton, Thomas N. N.
    POWDER DIFFRACTION, 2023, 38 (01) : 37 - 42
  • [2] Crystal structure of deracoxib, C17H14F3N3O3S
    Kaduk, James A.
    Gindhart, Amy M.
    Gates-Rector, Stacy
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2023, 38 (01) : 64 - 68
  • [3] Crystal structure of ponazuril, C18H14F3N3O6S
    Kaduk, James A.
    Gates-Rector, Stacy
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2022, 37 (04) : 225 - 229
  • [4] Crystal structure of nilotinib, C28H22F3N7O
    Kaduk, James A.
    Zhong, Kai
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2015, 30 (03) : 270 - 277
  • [5] Crystal structure of diclazuril, C17H9Cl3N4O2
    Kaduk, James A.
    Gates-Rector, Stacy
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2022, 37 (04) : 230 - 234
  • [6] Crystal structure of lacosamide form I, C13H18N2O3
    Kaduk, James A.
    Zhong, Kai
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2015, 30 (03) : 224 - 230
  • [7] Crystal structure of paliperidone, C23H27FN4O3
    Kaduk, James A.
    Zhong, Kai
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2016, 31 (02) : 135 - 141
  • [8] Crystal structure of pomalidomide Form I, C13H11N3O4
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2021, 36 (02) : 114 - 119
  • [9] Crystal structure of norgestimate, C23H31NO3
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2016, 31 (04) : 274 - 278
  • [10] Crystal structure of vismodegib, C19H14Cl2N2O3S
    Kaduk, James A.
    Gates-Rector, Stacy
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2023, 38 (01) : 1 - 6